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The mitochondrial intramembrane rhomboid protease Parl has
been implicated in diverse functions in vitro, but its physiological
role in vivo remains unclear. Here we show that Parl ablation in
mouse causes a necrotizing encephalomyelopathy similar to Leigh
syndrome, a mitochondrial disease characterized by disrupted
energy production. Mice with conditional Parl deﬁciency in the
nervous system, but not in muscle, develop a similar phenotype
as germline Parl knockouts demonstrating the vital role of Parl
in neurological homeostasis. Genetic modiﬁcation of two major
Parl substrates, Pink1 and Pgam5, do not modify this severe
neurological phenotype. Parl-/- brain mitochondria are affected
by severe ultrastructural changes, defects in Complex III activity,
coenzyme Q biosynthesis, and mitochondrial calcium metabolism.
Parl is necessary for the stable expression of Ttc19, required for
Complex III activity, and of Coq4, essential in coenzyme Q biosyn-
thesis. Thus, Parl plays a previously overseen constitutive role in
the maintenance of the respiratory chain in the nervous system,
and its deﬁciency causes progressive mitochondrial dysfunction,
structural abnormalities leading to neuronal necrosis and Leigh-
like syndrome.
rhomboid protease j mitochondria j neurodegeneration j respiratory
chain j Leigh syndrome
INTRODUCTION
PARL represents the only known mitochondrial member of the
rhomboid family (1). Rhomboids are evolutionary conserved in-
tramembrane cleaving proteases and pseudo proteases involved
in a variety of functions (2). Their broad biological significance
is reflected in their pathological relevance for prevalent human
diseases, including cancer and neurodegenerative diseases (2).
The crucial role of PARL in cellular homeostasis is illus-
trated by the lethal multisystem phenotype of Parl deficient
mice (Parl-/-), associated with muscle atrophy and increased
apoptosis in thymus and spleen (3). The faster cytochrome c
release and cristae remodeling in vitro, and the increased cell
death of Parl-/-mouse embryonic fibroblasts (MEFs) treated with
apoptosis-inducing agents rescued by overexpressed intermem-
brane space targeted Opa1, led to the proposal that Parl plays
a role in cristae remodeling and cytochrome c release during
apoptosis. The authors suggested that decreasedOpa1 processing
by Parl was causative to these apoptotic phenotypes. Later studies
identified Oma1 and Yme1l (4) as the proteases cleaving Opa1
and questioned Opa1 as a Parl substrate. More recently, Parl
has been implicated in the processing of other substrates in
cultured cells (5–10). Two substrates, Pink1 and Pgam5, are of
particular interest as they are implicated in Parkinson’s disease
(11, 12). Both accumulate in Parl-/- cells (6–8, 13), but it is unclear
whether this accumulation is detrimental (2). A recent elegant cell
biology study proposed that PARLexerts pro-apoptotic effects via
misprocessing of the mitochondrial Diablo homolog (hereafter
Diablo) (10). However, this is difficult to reconcile with the
lethality of Parl-/-mice and the proposed protective function of
Parl (3). Overall, the available data have led to contradictory
speculations with regard to the role of Parl in apoptosis (3, 10),
mitochondrial function (3, 14), morphology (3, 14, 15), mitophagy
(16–18) and claims have not been further substantiated in vivo.
More importantly, the cause of death of the Parl-/-mice, and
therefore the physiological role of this protease has remained
unresolved. To address these questions, we re-investigated Parl
deficient mice. In contrast with our previous report, we find now,
in addition to the described phenotypes in peripheral tissues,
that Parl deficiency causes a necrotizing encephalomyelopathy
closely resembling Leigh syndrome, a human mitochondrial dis-
ease caused by impaired respiratory chain defects (19). A simi-
Signiﬁcance
Parl is a peculiar protease in the inner membrane of mito-
chondria with important but unclear physiological roles, and
with links to Parkinson’s disease and diabetes. Most studies,
including the original characterization of the Parl knockout
mouse and others performed in vitro, have focused on apopto-
sis. We show that Parl deﬁciency in the nervous system alone
or in the complete animal causes severe neurodegeneration
associated with necrosis resembling the human mitochondrial
disease Leigh syndrome. By combining genetic, biochemical,
and proteomic approaches, we show that Parl plays an essen-
tial physiological role in the nervous system being required for
the maintenance of mitochondrial structure and function at
the level of Complex III, Coenzyme Q, and calciummetabolism.











































































































































Fig. 1. A Leigh-like encephalomyelopathy drives Parl-/- phenotype. (A) Severe vacuolar neurodegeneration in a 7 weeks-old Parl-/- mouse brain. H&E staining
(n≥ 12). Scale bar: 1250 µm. The insert shows a detail of the thalamus (scale bars: 100 µm). (B) Severe neuronal loss in the gray matter of Parl-/- lumbar spinal
cord at 7 weeks of age. NeuN staining (n=3 for WT, n=6 for Parl-/-). Scale bar: 125 µm. (C) Anti-Gfap staining showing prominent astrogliosis in Parl-/- medulla
oblongata at 7 weeks of age (n=3 for WT, n=6 for Parl-/-). Scale bar: 125 µm. (D) Anti-Iba1 staining in superior colliculus in the midbrain at 7 weeks (n=3
for WT, n=6 for Parl-/-). Scale bar: 125 µm. (E) Combined Luxol fast Blue and H&E staining showing preservation of the white matter (stained in blue) in 7
weeks-old Parl-/-mice (n=3 for WT, n=7 for Parl-/-). Scale bar: 750 µm. (F)Parl in situ hybridization. DG: dentate gyrus; TLM: thalamus; PC: pyriform cortex; HY:
hypothalamus. Scale bar: 1 mm. The insert shows strong Parl expression in WT reticular neurons. (G) H&E staining of the inferior colliculus in the midbrain of
a 7-week old Parl-/- mouse showing vascular proliferation (n>10). Scale bar: 50 µm. (H) Focal hemorrhage in the olivary nucleus of a 7-week old Parl-/- mouse.
Bilateral symmetrical hemorrhages have been detected in brainstems of 4 out of 7 Parl-/- mice at 7 weeks of age and in none of the WT littermates. Scale
bar: 250 µm. The insert shows bilateral symmetrical hemorrhages in medulla oblongata (arrows). (I) Survival curves of WT (n=14), Parl-/- (n=14), ParlL/L::NesCre
(n=15) and ParlL/L::CkmmCre mice (n=13). (J) Western blot analysis of Parl protein in brain, thymus, spleen, muscle, and liver mitochondria isolated from 7 weeks
old WT and Parl-/-, and 13 weeks old ParlL/L:::NesCre-mice (n=3). Ndufs3 is the loading control. (K) H&E staining of midbrains from 10 weeks old ParlL/L::NesCre
(n=4),and 7 weeks-old Parl-/- mice (n=12). Scale bar: 380 µm. (L-O) Severe atrophy of the skeletal muscle (L), liver (M), spleen (N) but normal testis size (O) in
11-week old ParlL/L::NesCre- male mice compared to an age matched WT control (n>15). (P)H&E staining of thymus from WT (age: 7 weeks; n=6), ParlL/L::NesCre
(age 10-13 weeks; n=4), and Parl-/-- mice (age:7 weeks; n=12). ParlL/L::NesCre and Parl-/-- thymus are atrophic.Scale bar: 200 µm.
lar multisystem phenotype is seen both in the full Parl-/- and in
ParlL/L::NesCre mice with a specific deletion of Parl in the nervous
system. The striking neurodegeneration is not associated with











































































































































Fig. 2. Parl-/-neurodegeneration is preceded by mitochondria ultrastructural changes and is characterized by necrosis. (A) Electron microscopy of medulla
oblongata neuronal mitochondria of WT and Parl-/- over time, at 3, and 7 weeks of age. The right panel represents a high magniﬁcation inset of the
images shown on the left. Scale bar:1 µm. (B) Semithin section stained with toluidine blue shows vacuolization and disintegration of neurons (black
arrowheads) in medulla oblongata of 7 weeks old Parl-/- mouse compared to a WT. Scale bar: 50µm. (C) Representative electron microscopy images showing
intracellular vacuolization (black arrowheads) in a 7 week-old Parl-/- thalamic neuron. Scale bar: 5µm. (D)Permeability of mitochondrial outer membrane by
Ascorbate/TMPD-driven oxygen consumption rates in 6 weeks oldWTand Parl-/- puriﬁed free brain mitochondria (n=7) before and after addition of exogenous
10 µM cytochrome c. Data represent average ± SD. (E).Western blot of WT and Parl-/- brain cytosolic and mitochondrial fractions at 7 weeks of age (n=3)
showing absence of cytochrome c into the cytosol. Anti-Aif1 and anti-Tubulin are mitochondrial and cytosolic markers respectively. Hom: total homogenate;
cyt: puriﬁed cytosol; mito: puriﬁed mitochondria. (F) Immunoblot of 7 week-old WT and Parl-/-nuclei-enriched brain fractions with anti-Parp antibody. (G)
Activated caspase 3 staining shows absence of positive neurons, in 7 weeks Parl-/- thalamus despite the presence of severe neurodegeneration (n=4). Scale
bar: 100 µm. (H) In the dentate gyrus, a brain area that does not show degeneration in germline or in ParlL/L::NesCre mice, activated caspase 3 staining shows
scattered positive neurons (black arrows) to the same extent in WT and Parl-/- mice (n=4). Scale bar: 50 µm.(I)Cultured primary neurons were treated with 10
µM etoposide for 24 hours and lysed. Total neuronal lysates were immunoblotted with anti-Caspase-3 and anti-Parp antibodies. The black arrows indicate the
proteolytic fragments of activated caspase 3 and Parp. Actin is the loading control.
the underlying mechanism. We show that necrosis in Parl-/- brains
is preceded by progressive mitochondrial structural changes and
by specific defects of the respiratory chain at the level of Complex











































































































































Fig. 3. Pink1 and Pgam5 do not interact genetically with Parl deﬁciency
in vivo. (A) Validation of Parl-/-/Pgam5-/-, Parl-/-/Pink1-/- and Pink1-/-/Pgam5-/-
double knockout mice, and Parl-/-/Pgam5-/-/Pink1-/- triple knockout mice.
Brain mitochondria were isolated from mice of the indicated genotype
and immunoblotted with Parl, Pink1, and Pgam5 antibodies. The white
arrow indicates the mature form of Pgam5, the black arrow indicates the
unprocessed form, the grey arrow indicates alternatively processed form
in Parl-/-mitochondria. Hsp60 is the loading control. (B) Survival curves of
Parl-/- (n=10), Pink1-/-/Pgam5-/- (n=10)-, Parl-/-/Pink1-/- (n=17), Parl-/-/Pgam5-/-
(n=16), Parl-/-/Pgam5-/-/Pink1-/-(n=13). (C) H&E staining of midbrain coronal
sections of 7 week-old mice of the indicated genotypes (n>3). Scale bar: 500
µm.
ations in mitochondrial calcium metabolism. Thus, Parl has an
essential physiological role in the maintenance of mitochondrial
structure and function, which is severely impaired when Parl is
ablated, causing Leigh-like neurodegeneration. We discuss how
these novel insights affect our previous interpretations of the
Parl-/- phenotype in vivo.
RESULTS
Parl deficiency in the nervous system leads to Leigh syndrome
Parl-/- mice develop normally up to the age of 40 days, af-
ter which they progressively lose weight (3). From the age of
six weeks, they show rapidly progressive locomotor impairment,
paresis of the lower limbs, hunchback deformity, and dyspnea
(Movie S1). They die before the age of eight weeks from a
multisystem phenotype with atrophy of skeletal muscle, thymus
and spleen (3), without a clear explanation. Immune deficiency is
unlikely the cause of death because thymus and spleen become at-
rophic only few days before death when mice are already severely
affected. Moreover mice are bred in specific pathogen free con-
ditions and do not develop opportunistic infections, leaving open
the question of which essential vital function is compromised by
Parl deficiency. These clinical signs led us to ask whether this
phenotype was caused by neurological involvement. Examination
of the brain and spinal cord from Parl-/- mice indeed showed a
previously overlooked subcortical vacuolar encephalomyelopathy
closely resembling Leigh syndrome (Fig. 1A-H). Leigh syndrome
is a lethal mitochondrial disease characterized by neurological re-
gression and pathologically by vacuolar degeneration and necro-
sis of the brainstem, basal ganglia and spinal cord, reactive gliosis
and vascular proliferation (20). Vacuolization of the neuropil was
first detectable in Parl-/- mice at five weeks of age, initially circum-
scribed in the brainstem and in the gray matter of the spinal cord,
and then progressively extending anteriorly to hypothalamus,
thalamus, deep cerebellar nuclei, and the cingulate cortex. Other
areas of the brain, notably most of the cortex, hippocampus and
the substantia nigra, were spared. Neuronal loss was detectable
by loss of NeuN-positive cells (Fig. 1B). Neurodegeneration was
accompanied by extensive astrogliosis and microgliosis, indicated
by Gfap (Fig. 1C) and Iba1 (Fig. 1D) immunoreactivity. Luxol-
fast blue, a staining used to visualize the white matter, showed
comparable reaction in WT and Parl-/- mice (Fig. 1E). Consistent
with neuronal involvement, in situ hybridization shows that Parl
mRNA expression was particularly abundant in neurons (Fig.
1F). In advanced stages, vascular proliferation became evident
(Fig. 1G), and symmetrical hemorrages were frequently observed
at 7 weeks of age in the most severely affected areas of the
brainstem and spinal cord (Fig. 1H). When Parl was specifi-
cally ablated in the nervous system using a Nestin-Cre driver
(ParlL/L::NesCre) (Fig. 1J) a similar lethal phenotype was observed
as in the germline Parl-/-mice (Fig. 1I) including the Leigh-type
neuropathology (Fig.1K). Apart from a 4-weeks delay in lethality
and the absence of testis atrophy (Fig. 1O), these mice developed
the typical Parl-/- multisystem phenotype (3) with severe atrophy
of muscle, liver, spleen (Fig.1L-N), and thymus (Fig. 1P) despite
normal Parl expression in these tissues (Fig. 1J). To further assess
ectopic Cre mediated recombination in these peripheral tissues,
we evaluated the presence of recombination by PCR, followed by
high-resolution capillary electrophoresis (SI Appendix, Fig. S1A-
B). Parl-/- alleles were non-detectable in ParlL/L::NesCre spleen and
liver, and present to a very low percentage in thymus (2%) and
muscle (5%), consistent with the protein data. Thymus and spleen
became atrophic in ParlL/L::NesCre as in germline Parl-/- mice only
in preterminal stages of the disease when the mice were already
affected by severe neurological deficits. Conversely, deletion of
Parl in striated muscle in ParlL/L::CkmmCre knockout mice using
Cre expression driven by the Creatine kinase promoter did not
compromise survival at least up to the age of 18 months nor led
to overt locomotor deficits (n=13, Fig. 1I). Altogether, these data
suggest that Parl deficiency in the nervous system is sufficient
to recapitulate the lethal multisystem phenotype of germline
Parl-/-mice, except the gonad atrophy.
Parl deficiency causes early neuronal mitochondrial ultra-
structural abnormalities followed by neuronal necrosis
To characterize mitochondrial ultrastructure and the mor-
phological features of cell death induced by Parl deficiency in the
brainwe performed electronmicroscopy. At 3weeks of age, which
is before the occurrence of clinical signs or histopathological
lesions, Parl-/- but not WT neurons of medulla oblongata, dis-
played scattered swollen mitochondria with abnormal cristae and
a translucent matrix (Fig.2A). At later time points, mitochondrial
ultrastructural abnormalities became progressively more severe
and diffuse in the context of progressive neuronal vacuolization,
swelling and loss of integrity (Fig. 2B-C). This picture is indicative











































































































































Fig. 4. Defects in CIII and CoQ in Parl-/-brain mitochondria. (A) Immunoblot of mitochondrial respiratory chain subunits (CI-CV), Tom20, inWT and Parl-/- whole
brain lysates at 3, 4, and 7 weeks of age (n=4). Actin is the loading control. (B)Representative trace illustrating the protocol for high-resolution respirometry
in neuronal mitochondria. The blue trace indicates the O2 concentration, the red trace indicates its time derivative. 50 µg puriﬁed synaptosomes were
loaded in Miro6 buffer. Digitonin (Digi) was titrated to achieve optimal synaptosomal permeabilization. Substrates: CI (PMG=pyruvate+malate+glutamate),
CII (Succ=succinate); CIV (ASC/TMPD=ascorbate+TMPD). Uncoupler: CCCP. Inhibitors: CI (ROT: rotenone); CIII (Aa: Antimycin a); CIV (KCN: potassium cyanide).
Cyt c: cytochrome c. Respiratory states are indicated between red dashed lines. CI LEAK=CI-driven leak respiration. CI OXPHOS: CI-driven phosphorylating
respiration. CI+II OXPHOS: phosphorylating respiration driven by combined activation of CI and II. CI+II ET: electron transfer capacity driven by combined
CI and II. CII ET: electron transfer driven by CII. CIV: CIV-driven respiration. Cytc: exogenous cytochrome c is added to evaluate the integrity of the outer
mitochondrial membranes. H2O2 in the presence of catalase is used to reoxygenate the chamber. (C)Quantiﬁcation of the respiratory states of permeabilized
synaptosomes isolated from six-weeks old WT and Parl-/- mice (n=7) as from the protocol in C. (D)Enzymatic activities of individual respiratory chain complexes
and CII+III in brain mitochondria from 6 weeks old WT and Parl-/-mice (n=5) normalized to citrate synthase. (E)Blue-native-gel electrophoresis of puriﬁed brain
mitochondria from 7 weeks old WT and Parl-/-mice, followed by immunoblotting with anti-Ndufs3 (CI), anti-Sdha (CII), anti-Uqcrfs1 (CIII), anti-Cox4 (CIV),
anti-Atpb (CV). The arrow indicates the upward mobility change of CIII2 in Parl-/- (n=3). (F) Mitochondrial DNA, normalized by nuclear DNA in 7 weeks old
WT and Parl-/-brainstems (n=5). (G) Concentration of total CoQ (Q9+Q10) measured by HPLC in brain tissue from 7 weeks old WT and Parl-/-mice (n=5).(H)Ratio
between reduced and oxidized CoQ from the experiment in G. The bar graphs indicate the average ± SD. Statistical signiﬁcance has been calculated by two
sided student t test: *= p<0,05; **=p<0,01; ***=p<0,001;****=p<0,0001.
were consistently absent. Similar abnormalities were present in
neuronal mitochondria from ParlL/L::NesCre mice (SI Appendix,
Fig.S2). Since Parl has been linked previously to apoptosis (3, 10)
we investigated further its contribution to the neurodegeneration.
During apoptosis, the outer mitochondrial membrane becomes
permeable, and cytochrome c is released from the mitochon-
drial intermembrane space to the cytosol leading to proteolytic
activation of executioner caspases and Parp. We analyzed mito-
chondrial outer membrane permeability of brain mitochondria
isolated from symptomatic Parl-/- mice by measuring the enhance-
ment of Complex IV-driven (CIV) respiration before and after
addition of exogenous cytochrome c, which is unable to reach
CIV if outer membranes are intact. Exogenous cytochrome c did
not significantly enhance CIV-driven respiration in both WT and
Parl-/- brain mitochondria (Fig. 2D), indicating intactness of outer
mitochondrial membranes even in advanced stages of the disease
with severe neurodegeneration. Consistently, cytochrome c was
undetectable in purified brain cytosols from Parl-/- brains (Fig.
2E), and the expression of full length Parpwas similar inParl-/- and
WT brains without evidence of proteolytic activation (Fig. 2F).
Accordingly, we did not see TUNEL-positive cells in the degener-
ating brain areas, notably brainstem, thalamus, hypothalamus at
serial time points ranging from asymptomatic to late stage of the
disease (SI Appendix, Fig. S3A). TUNEL-positivity was restricted
to few scattered cells undergoing developmental apoptosis in
periventricular areas not affected by Parl-/- neurodegeneration.
This was notmore severe inParl-/- than inWTbrains.We obtained











































































































































Fig. 5. Alterations in calcium uptake and membrane potential in Parl-/- brain
mitochondria.(A) Calcium retaining capacity of puriﬁed brain mitochondria.
On the left a representative trace of a typical ﬂuorimetric experiment
using Calcium Green illustrating the protocol detailed in methods section.
Mito=mitochondria; CaG=Calcium Green; CaCl2=calcium chloride titrations..
EGTA=calcium chelator. On the right the graph bars represent the quan-
tiﬁcations of the maximal amount of exogenous calcium retained by WT
and Parl-/- brain mitochondria puriﬁed from 6 weeks old mice before ob-
serving calcium efﬂux (n=5). (B) Mitochondrial membrane potential (Δψ)
in brain mitochondria using safranin. A typical ﬂuorimetric experiment
illustrating the protocol detailed in the method section. Mito=mitochondria;
CCCP=uncoupler. (C-D) Quantiﬁcations of the experiments described in A
using exactly 150 µg brain mitochondria from 7weeks oldWT and Parl-/- mice
(n=5 in C, n=4 for in D). (C) Δψ using the CI substrates glutamate and
malate (GLUT/MAL) without (leak state) and with ADP (phosphorylating
state). (D) Δψ using the CII substrate succinate in presence of the CI inhibitor
rotenone without (leak state) and with ADP (phosphorylating state). The
graph bars indicate the average ± SD. Statistical signiﬁcances by two-sided t
test: **=p<0.005; ***=p<0.0005
Parl-/- (Fig.2G-H) and in ParlL/L::NesCre mice (SI Appendix, Fig.
S3B), indicating that apoptosis is not overtly altered in Parl
deficient brains. Conversely, active Caspase 3 immunostaining of
atrophic thymus of severely affected Parl-/- mice showed strong
positivity (SI Appendix, Fig. S3C) as previously reported (3).
However, an identical thymus pathology (Fig. 1P) and caspase-
positivity (Fig.S3C) were also seen in late stage ParlL/L::NesCre
despite normal Parl expression in this tissue (Fig. 1J) indicating
that this phenotype can be fully induced by deficiency of Parl in
the nervous system alone. Treatment of primary cultures of Parl-/-
and WT neurons with the pro-apoptotic drug etoposide showed
similar proteolytic activation of Caspase 3 and Parp indicating
that apoptosis execution is not overtly blocked in cultured neu-
rons (Fig. 2I). All together, these data indicate that the striking
neurodegeneration induced by Parl deficiency is preceded by
mitochondrial ultrastructural abnormalities that accumulate with
time. The neurodegeneration is characterized by neuronal necro-
Fig. 6. Restricted changes in the brain mitochondrial proteome induced
by Parl deﬁciency explain the CIII and CoQ defects. (A)Volcano plot show-
ing differentially regulated proteins in Parl-/- brain mitochondria puriﬁed
from 5 week-old WT and Parl-/-brains (n=3) analyzed by mass spectrometry.
Signiﬁcantly differentially regulated proteins are distributed outside the
volcano cutoff of fold changes >2 and p value <0.05. Differentially expressed
mitochondrial proteins are plotted in red. Previously reported Parl substrates
that did not reach statistical signiﬁcance are plotted in black. The non-
mitochondrial proteins Trabd, Bcap31, Bcan, Eif1a, and Setdb, were not
included in the graph since appeared similarly expressed in the validation
experiment in Fig.6B. (B)Validation of the mass spectrometry results and of
previously reported Parl substrates Pink1, Stard7, Clpb, Htra2, Opa1. Brain
mitochondria isolated from WT, Parl-/-, and ParlL/L::NesCre, were analyzed by
immunoblotting. The white arrows indicate the mature (processed) form of
the protein, the black arrows indicate unprocessed forms, the grey arrows
indicate alternatively processed forms in Parl-/-mitochondria. The asterisk
indicates bands of uncertain signiﬁcance. (C)Time course of Ttc19, CoQ
biosynthesis proteins and Sqrdl in WT and Parl-/-brains. Total brain lysates
fromWT, Parl-/- sacriﬁced at 1, 3, 5, and 7 weeks of age (n=3), were analyzed
by immunoblotting (original blots in SI Appendix, Fig.S8). The graph bars
indicate the quantiﬁcations. Each protein was normalized with the loading
control Hsp60 and expressed as % relative to the WT. .
sis without overtly altering apoptosis. The increased apoptosis in











































































































































Fig. 7. Ttc19 deﬁciency causes alterations in CIII and CoQ red/ox but non
in CoQ concentration in the nervous system. (A)Generation of Ttc19-/- mice
by Crisper/Cas9 technology. Ttc19-/- mice have a 5 base pairs deletion in
the ﬁrst exon. (B) Immunoblot analysis of brain and muscle mitochondria
with anti Ttc19 and anti Coq4 antibodies. Hsp60 is the loading control. (C)
Blue-native gel-electrophoresis of puriﬁed brain mitochondria from 7 weeks
old WT and Ttc19-/-mice, followed by immunoblotting with anti-Ndufs3 (CI),
anti-Sdha (CII), anti-Uqcrfs1 (CIII), anti-Cox4 (CIV), anti-Atpb (CV). The arrow
indicates the upward mobility change of CIII2 in Ttc19-/- mitochondria. (D)
Concentration of total CoQ Q (Q9+Q10) in brains from 7 weeks old WT
and Ttc19-/-mice (n=5). (E)Ratio between reduced and oxidized CoQ from
the experiment in D. The bar graphs indicate the average ± SD. Statistical
signiﬁcance has been calculated by two sided student t test: ****=p<0,0001.
Parl-/- Leigh-like syndrome is not caused by misprocessing of
Pink1 and Pgam5
Next we wondered to what extent the neurodegenerative
phenotype of Parl-/- mice can be attributed to misprocessing of
the best characterized substrates of Parl, Pink1 (16, 6, 8), a
mitochondrial kinase, and Pgam5, a mitochondrial phosphatase
(9). Both have roles in neurological diseases (11, 12) and in
mitophagy (12, 21). Pgam5 has also been linked to regulation
of multiple cell death pathways including necroptosis (22). How-
ever, the contribution of Pink1 and Pgam5 misprocessing to
the Parl-/- phenotype is not known (1). Expression of Lc3, p62,
and Bnip3 (Figure S4A), which are markers of macroautophagy,
and mitochondrial protein ubiquitination (Figure S4B), which
labels proteins of dysfunctional mitochondrial for degradation
by mitophagy, were not modified in Parl-/- brains, indicating un-
altered steady state levels of autophagy in Parl-/- brain. Pink1
was barely detectable in WT mitochondria, while a remarkable
accumulation of Pink1 was seen in Parl-/- brain mitochondria
(Fig. 3A). Similarly, the unprocessed full-length form of Pgam5
strongly accumulated in Parl-/-mitochondria while the processed
form of Pgam5 migrated slightly faster than in WT mitochon-
dria, indicating an alternative Parl-independent cleavage. To test
whether accumulation of these unprocessed forms of Pink1 and
Pgam5 inParl-/-mitochondria drivesParl-/- neurodegeneration, we
generated a series of double Parl-/-/Pink1-/-, Parl-/-/Pgam5-/-, and
triple Parl-/-/Pink1-/-/Pgam5-/- combined knockout mice (Fig.3A).
Surprisingly, the Parl-/- phenotype was unmodified by simultane-
ous deletion of Pink1, or Pgam5, either alone or together, and
all these mouse strains invariably died at a similar age as the
single Parl-/- (Fig.3B) affected by similar Leigh-like syndrome
(Fig.3C). To test whether deficient proteolytic products of Pink1
and Pgam5 generated by Parl were essential, we also generated
Pink1-/-/Pgam5-/-mice. Conversely, Pink1-/-/Pgam5-/- mice had a
normal lifespan (Fig. 3B) beyond the age of two years without any
overt clinical or neuropathological phenotype (Fig. 3C) indicating
that misprocessing of Pink1 and Pgam5 alone or together do not
explain the Parl-/- associated Leigh-like syndrome
Parl deficiency leads to severe respiratory chain defects con-
verging on Complex III and Coenzyme Q
Leigh syndrome is caused by different genetic defects that ul-
timately impairmitochondrial energy production (19). Therefore,
we evaluated how brain mitochondrial function is compromised
by absent Parl expression. Since Parl has been previously linked
to differences inmitochondrial biogenesis (14), we asked whether
mitochondrial mass is affected in Parl-/- brains. Expression of
respiratory chain subunits and of the outer membraner protein
Tomm20 was similar in WT and Parl-/- brains at any age (Fig. 4A),
indicating unaltered mitochondrial mass. Mitochondrial DNA
abundance was also not significantly different (Fig. 4F). Next,
we measured oxygen consumption rates in neuronal mitochon-
dria derived frompermeabilized synaptosomes by high-resolution
respirometry supplying consecutively substrates and specific in-
hibitors for CI, II, and IV as illustrated in Fig. 4B. Importantly, at
three weeks of age, which is three weeks before the first clinical
signs of Parl-/- mice, respiration was comparable betweenWT and
Parl-/- brain mitochondria (SI Appendix, Fig. S5A). However, at
six weeks of age, at the onset of the symptomatic stage, both
ADP stimulated respiration (OXPHOS), reflecting the maximal
capacity to generate ATP, and uncoupled respiration, providing
an estimate of the maximal electron transfer capacity (ET), were
severely diminished in Parl-/- neuronal mitochondria (Fig. 4C).
Oxygen consumption was similarly decreased when using only CI
substrates (CI OXPHOS), or CI and II substrates simultaneously
in both phosphorylating and uncoupled states (CI+II OXPHOS
and ET). Respiration from cytochrome c oxidase (CIV) was
slightly, although significantly compromised (Fig. 4C). To localize
precisely the respiratory chain defect, we measured the maximal
enzymatic activities of each Complex (CI-CIV) and of ATP syn-
thase in brain mitochondria, as well as the coupled enzymatic
activity of CII+III. This enzymatic assay explores segment CII-
coenzyme Q-CIII. We detected a severe enzymatic defect of
CIII and of CII+III (Fig. 4D), while CII and IV activities were
slightly, although still significantly, decreased. Next, we wondered
whether the deficient CIII activity was due to abnormal CIII
assembly. Blue-native-gel electrophoresis of brain mitochondria
showed effective assembly and maturation of the four respiratory
chain CI-IV and of ATP synthase, as well as preserved formation
of the super complex (Fig. 4E). The terminal component of CIII,
Uqcrfs1, was normally incorporated, but CIII2 showed consis-
tently a slightly lower electrophoretic mobility in Parl-/- compared
to WT mitochondria (Fig. 4E). An identical CIII2migration ab-
normality has been recently reported in mitochondria deficient
of Ttc19 (23) and gene mutations in TTC19 cause human Leigh
syndrome (24). Next to investigate unambiguously the possibility
of CoQ deficiency, we directly measured CoQ levels (CoQ9+10) in
brain extracts and the ratio between reduced and oxidized CoQ,
a sensitive marker of the electron transfer efficiency (25). CoQ
deficiency is one of the established causes of Leigh syndrome
(19). Remarkably, total CoQ levels were severely decreased in
Parl-/- brains at 7 weeks of age (Fig. 4G). Moreover, the ratio be-
tween reduced and oxidized forms of CoQ was strongly increased
(Fig. 4H) indicating a marked impairment in CoQH2 oxidation,
consistent with the impaired CIII activity. These changes were in
contrast to the respiration defect, already severe at the presymp-
tomatic age of 3 weeks (SI Appendix, Fig.S5B) indicating that
CoQ deficiency is an early effect of Parl deficiency. In conclusion,
Parl is required to prevent severe alterations in the respiratory
chain of brain mitochondria characterized by CIII and CoQ
biosynthesis defects.
Altered calcium metabolism, membrane potential, and reac-
tive oxygen species production in Parl-/- brain mitochondria
Next we wondered whether Parl deficiency compromises











































































































































Increased production of reactive oxygen species (ROS) is a possi-
ble consequence of respiratory chain defects. Therefore, we mea-
sured ROS production rates in brain mitochondria supplemented
with both CI and II substrates fluorometry with the H2O2 sensor
Amplex Ultrared as illustrated in SI Appendix, Fig.S6A. ROS
production was similar in all experimental conditions except for
a slight increase only with CI substrates (SI Appendix, Fig.S6B).
Consistently, protein carbonylation, a commonly used biomarker
to assess oxidative stress ex vivo, was not overtly increased in
Parl-/- brain mitochondria or total homogenates compared to WT
(SI Appendix, Fig.S6C-D).
Mitochondrial calcium is an important determinant of cell
death and is bi-directionally related to energy metabolism. Both
excessive levels of mitochondrial calcium and reduced buffering
of cytosolic calcium can be detrimental (26). Therefore, we mea-
sured the maximal calcium retention capacity in purified brain
mitochondria progressively loaded with calcium (Fig 5A, left).
Parl-/- brain mitochondria showed a severely reduced calcium
capacity (Fig 5A, right). To investigate whether this defect could
be explained by mitochondrial depolarization, we measured the
mitochondrial potential (Δψ) in brainmitochondria suppliedwith
CI and CII substrates in the absence and in the presence of
ADP (Fig 5B). In this experiment, Δψ is inversely related to the
fluorescence of safranin which is quenched in the mitochondrial
matrix of polarized mitochondria. As expected, the addition of
ADP consistently led to increased fluorescence, corresponding to
a drop inΔψwhich reflects the use of the proton gradient to drive
ATP synthesis, and the mitochondrial uncoupler CCCP led to a
further increase. Δψ in Parl-/- brain mitochondria was diminished
only in presence ofADP (in phosphorylating conditions), by using
bothCI and II substrates (Fig. 5C-D, right), while themaximalΔψ
measured in the absence of ADP was unaltered (Fig. 5C-D, left).
Therefore, the decreased mitochondrial calcium uptake, which is
evaluated in the leak state in the absence of ADP, is not simply
explained by mitochondrial depolarization. In conclusion, Parl
deficiency leads to severe alterations of mitochondrial calcium
metabolism and tomodest changes in oxidative stress in the brain.
Mitochondrial proteome changes induced by Parl deficieny
in the brain
We wondered what mitochondrial protein changes underlie
the observed CIII and CoQ defects in Parl-/- brains. We per-
formed a mass spectrometry-based proteome analysis of brain
mitochondria purified from WT and Parl-/- mice, leading to the
quantification of 781 out of 1085 proteins annotated in the mouse
mitochondrial proteome in Swissprot (Table S1). The volcano
plot showed that despite the dramatic phenotype, surprisingly
few mitochondrial proteins were differentially expressed (Fig.
6A), indicating selective effects of Parl on the mitochondrial
proteome. Among these, we found a striking downregulation of
the CIII regulating protein Ttc19 (23, 27) and of several proteins
required for CoQ biosynthesis (Coq3, Coq4, Coq5). We also no-
ticed the significant decrease of the sulfide-CoQ oxidoreductase,
which has been recently reported to decrease in human primary
CoQ defects (28). Ghitm, a multipass inner membrane protein
not previously linked to Parl, in contrast, decreased. Like Pink1
and Pgam5, also Diablo (10) increased in Parl deficient brain mi-
tochondria (Fig. 6A). Next, we validated these findings by western
blot in brain mitochondria from WT, Parl-/-, and ParlL/L::NesCre
(Fig. 6B). Since our proteomic approach identifies substrates
by expression changes, we decided to include in the validation
also the previously reported Parl substrates Htra2 (5), Opa1 (3),
Stard7, and Clpb (10), which were not significantly different in
our mass spectrometry analysis despite being covered (Fig. 6A).
Western blots confirmed the virtual disappearance of Ttc19, a
marked reduction of the CoQ proteins (Coq3,Coq4,Coq5), Sqrdl,
andGhitm, and altered cleavage of Ttc19, Pgam5, Diablo, Stard7,
and Clpb. The expression and processing of Htra2 andOpa1 were
not impaired (Fig. 6B). To correlate these protein changes with
the clinical phenotype, we checked their expression in brain tissue
over time, at the age of 1, 3, and 5 weeks, when Parl-/- mice are
still asymptomatic, and at 7 weeks, when the mice are severely
affected by neurological deficits (Fig. 6C, SI Appendix Fig. S7).
To further investigate the molecular basis of the CIII and
CoQ deficiency we included in this time course an extensive
panel of proteins required for CoQ biosynthesis (Fig 6C and SI
Appendix Fig. S8). The virtual disappearance of mature Ttc19
in Parl-/- brains at all ages indicates that Parl is required for
Ttc19 maturation and expression. Coq4 was also reduced in Parl-/-
brains already at 1 week of age (Fig. 6C and SI Appendix Fig.
S8), followed by decreased Coq3, Coq5, Coq6, Coq7, Coq9 and
of Sqrdl at later time points. Other proteins already affected at
the age of one week are Ghitm and Stard7 in addition to Pink1
and Pgam5, while Diablo accumulated only in late symptomatic
stages (SI AppendixFig. S7). Expression of Clpb, Htra2, andOpa1
was largely unaffected by Parl expression at all ages, except for a
tendency for increased expression of the short Opa1 isoform at 7
weeks of age (SI Appendix Fig. S7).
To explore to what extent the catalytic function of Parl is
involved in these protein changes, we checked the expression of
these proteins in stable Parl-/- MEFs expressing ParlWT or catalytic
inactive ParlS275A (SI Appendix, Fig. S9). We observed no altered
mobility of Coq4, Coq5, Sqrdl in Parl-/- culturedMEFs, suggesting
that they likely are not direct Parl substrates. In contrast, the
processing of Ttc19, Pink1, Pgam5, Stard7, Diablo, and Clpb was
clearly modified by expression of catalytically active Parl, but not
by mutant ParlS275A, confirming that Parl proteolytic activity is
required for the maturation of these proteins and that they are all
likely genuine Parl substrates (10). In contrast, we could again not
confirm differences in Htra2 and Opa1 processing in Parl-/- MEFs
suggesting that both are not Parl substrates in contrast to previous
reports (3, 5).
Effects of Parl deficiency on Ttc19 and Coq4 in liver and
muscle
To investigate to what extent Parl deficiency also affects
expression of Ttc19 and Coq4 in other organs than the brain,
we blotted extracts of liver and skeletal muscle from Parl-/-,
ParlL/L::NesCre and WT mice (SI Appendix, Fig. S10). As in the
nervous system, Ttc19 expression was almost absent in both
liver and skeletal muscle tissue of. Parl-/-mice only. Coq4 was
significantly diminished in both tissues, although to a lesser extent
in Parl-/- muscle compared to brain and liver. Next, we checked
CoQ concentrations and red/ox ratio as well as CIII activity in
muscle and found altered CIII activity and CoQ red/ox ratio
in. Parl-/-muscles but normal CoQ concentration. These data
indicate that Parl is required for the expression of Ttc19 andCoq4
in different organs in vivo, although Parl deficiency in muscle
compromises only CIII activity but not CoQ concentration.
Ttc19 deficiency causes CIII defects and altered CoQ red/ox
but not altered CoQ biosynthesis
To dissect the relationship between the Ttc19 deficiency and
the observed CoQ defects we generated Ttc19-/- mice (Fig. 7A-B).
These mice (20 out of 20) have not shown any reduced survival
although they display a slight reduction in locomotor activity at
one year of age. Neuropathological analysis of the brainstem
of Ttc19-/- mice at the age of seven weeks did not demonstrate
lesions(SI Appendix, Fig. S11), at difference with Parl-/- mice.
Blue-native-gel electrophoresis of Ttc19-/- brain mitochondria
showed a similar upward mobility shift of CIII2 as seen with Parl-/-
mitochondria (Fig. 7C). Coq4 expression (Fig. 7B) and CoQ
concentration (Fig. 7D) were normal but theCoQ red/ox ratio was
highly increased in Ttc19-/- (Fig. 7E) as in the Parl-/- brains (Fig.











































































































































altered CIII structure and function, but not the CoQ biosynthesis
deficit. Altogether, the data indicate that Parl is required for
the maintenance of CIII activity by stabilization of Ttc19, and
for efficient CoQ biosynthesis in the brain by stabilizing Coq4
expression (SI Appendix, Fig.S12A-B).
DISCUSSION
This work reveals an essential role of Parl for the homeostasis
of the nervous system. Deficiency of Parl in the nervous tissue
whether isolated or in the context of systemic Parl knockout, leads
to severe neurodegeneration similar to the CI deficient Ndufs4-/-
mouse (29, 30), the only currently available mouse model for
Leigh syndrome. Although caution is needed before extrapolat-
ing from mouse to human diseases, the current study prompts to
investigate whether PARL gene mutations are present in human
patients with unexplained Leigh-like syndrome. Deletion of Parl
in the nervous system alone in ParlL/L::NesCre largely mimics the
germline Parl-/- phenotype, like Ndufs4L/L::Nes-Cre recapitulates
that of germline Ndufs4-/-, indicating that in both models the
nervous system involvement drives the disease. This observation
demonstrates that the Leigh syndrome is the elusive cause of the
multisystem lethal phenotype previously decribed in Parl-/- mice
(3). Interestingly, severe neurological alterations have also been
observed in flies carrying mutations in rhomboid-7 (31), the fly
orthologue of Parl. Therefore, specific deletion of Parl in the
nervous system also causes severe atrophy of skeletal muscle,
thymus, and spleen as in germline Parl-/- mice (6), although with a
delay of about one month. Nonspecific Cre recombinase activity
driven by Nestin was very limited or undetectable in these tissues
and Parl protein expression unaffected, therefore very unlikely
contributing to these ParlL/L::NesCre phenotypes. Moreover, the
lack of overt muscle atrophy and of lethality in mice with specific
deletion of Parl in muscle, as opposed to the nervous system,
indicates that the severe muscle atrophy is mainly a consequence
of the neurodegeneration. Brain specific deletion of the mito-
chondrial protease Htra2 affects thymus and spleen in a similar
way as brain specific Parl deficiency (32). Such immunological
phenotypes can be caused by a variety of general stress conditions
that trigger increased secretion of corticosteroids and other stress
hormones which induce apoptosis in these tissues (33). Hind limb
unloading for instance induces the distinctive depletion of double
positive CD4+CD8+ T lymphocytes that was also observed in
Parl-/- thymus and a drop of B lymphocytes as was seen in Parl-/-
spleen (3), but general stress conditions such as malnutrition
(34), or neurological diseases (35) can have similar effects on
apoptosis in thymus and spleen, at least in mice. This is consistent
with the observation that Parl-/- and ParlL/L::NesCre mice develop
these immunological manifestations only in late stages of the
neurological disease.
Since the original description of Parl-/- mice (3), many studies
have focused on possible links between Parl and apoptosis in
vitro with controversial results (3, 5, 10). Here we were unable
to confirm a role of Parl in apoptosis in vivo (3), instead we
observe a severe necrotic neuronal phenotype. We speculate
that the necrotic encephalopathy may represent a tissue specific
consequence of the severe structural and functional damage that
progressively accumulate in Parl-/- neuronal mitochondria, rather
than the result of a direct gatekeeping activity of Parl in regulated
necrosis machineries. Although we were not able to define in
further detail whether necrosis is regulated in Parl-/- brains, the
neuropathological phenotype is consistent with the definition of
Leigh syndrome as a necrotizing encephalomyelopathy.
Surprisingly, despite the striking neuropathology, the absence
of Parl affects only a very circumscribed proportion of the brain
mitochondrial proteome, which overlaps with recent proteomic
data obtained in HEK293 cells (10). One limitation of our pro-
teomic approach is that it only evaluated protein expression but
not post-translational modifications and in particular cleavage
sites were not analysed. At odd with previous observations (3,
5) and consistent with following reports (10, 36), the data pre-
sented here do not support Opa1 and Htra2 as substrates of
Parl. Conversely, we find several proteins differentially regulated
by Parl deficiency and several of them play important roles in
neurological diseases. We tested explicitly whether Pink1 and
Pgam5, two substrates of Parl involved in Parkinson’s disease
(11, 12) and mitophagy (12, 21), could drive the pathological
phenotype of Parl-/- mice. Rare PARL mutations have been re-
ported in rare patients with Parkinsons’s Disease (16). We tested
combined knockouts of these two substrates with Parl-/- and their
combined deletion in the presence of Parl to check whether the
accumulation or the loss of function of these two substrates would
play a role, but none of these experimentsmodulated or simulated
the Parl-/- phenotype. Thus, Pink1 and Pgam5 are not responsible
for the Leigh-like pathology in the Parl-/- mice indicating that
other biochemical mechanisms are involved.
Here we show that Parl plays an essential role in the respira-
tory chain independently from effects onmitochondrial mass (14)
by regulating proteins implicated in CIII and CoQ biogenesis.
Parl is required for the expression of Ttc19 (Fig. 6B-C) and
impaired proteolytic maturation of Ttc19 by Parl likely leads to
its degradation by alternative mitochondrial proteases. A recent
study reported that Parl is required for Ttc19 cleavage in vitro (10)
but the functional consequences were not investigated. Ttc19 is
involved in the turnover of the iron-sulfur protein Uqcrfs1 (23),
a structural subunit of CIII essential for the catalytic activity that
ensures CoQ oxidation. Here we show that impaired proteolytic
maturation and expression of Ttc19 in Parl-/- tissues results in
alteredCIII structure and catalytic activity as inTtc19-/-mitochon-
dria. The defective CIII activity is reflected by the increased frac-
tion of reduced vs oxidized CoQ. When CIII activity is normal,
CoQ red/ox ratio is low, while it is high whenCIII is dysfunctional,
in both Parl-/- and Ttc19-/- mice. In addition, and independently
from Ttc19, Parl modulates the expression of Coq4, a protein
required for the biosynthesis of CoQ (37). Intriguingly, the se-
vere CoQ deficiency that we found in Parl-/- brains is followed
by a secondary reduction in the expression of Sqrdl, as also
recently observed in primary CoQ defects (28). CoQ is a highly
hydrophobic molecule functioning as an electron carrier from
several metabolic pathways to CIII and as membrane antioxidant
(38, 39). The mechanism that links ablation of Parl to the reduced
Coq4 and the resulting CoQ deficiency in the brain is however
not yet clear, since we could not demonstrate that Coq4 is a
substrate of Parl. One possibility is that misprocessing of a still
undefined Parl substrate affects CoQ biosynthesis upstream of
Coq4, similarly to how the yeast intermediate peptidase Oct1p
ensures CoQ biosynthesis by cleaving Coq5p (40). An alternative
hypothesis is that Parl regulates CoQ biosynthesis indirectly by
generating an early stress response that precedes the respiration
defects. Recent observations show that the CoQ pathway is sensi-
tive to different mechanisms affecting mitochondrial DNA gene
expression in mouse heart tissue (41). However, in these models
Parl expression was upregulated, while Coq4 was unmodified or
increased, in contrast with what we observe in Parl-/- mice. Thus,
the effects caused by Parl deficiency are clearly different from
those reported in that study.
The Ttc19-/- mice data indicate that the CoQ deficiency is in-
dependent from the CIII defect and therefore Parl plays an essen-
tial role in themaintenance of the respiratory chain by two distinct
mechanisms. Interestingly, human mutations in TTC19 (24), and
in genes that induce CoQ deficiency (19) are independent causes
of Leigh syndrome. In addition, COQ4 haploinsufficiency cause











































































































































in mouse causes only mild neurodegeneration at advanced ages
(23), and accordingly we did not observe the massive brainstem
encephalopathy in Ttc19-/- of Parl-/- mice at comparable age (SI
Appendix Fig. S11). One hypothesis is that the respiratory chain
dysfunction determined by the combination of the CIII and CoQ
defects drive the Parl-/- Leigh-like encephalopathy. This might be
a possible explanation for the apparent resistance of the skeletal
muscle to Parl ablation, since in this tissue decreased Coq4 is
not associated with a significant drop in CoQ concentration, as
in the nervous system. However, we cannot exclude that other
mitochondrial functional and structural defects caused by Parl
deficiency could also contribute to the pathogenesis of the neu-
rodegeneration. We didn’t find a major impact of Parl deficiency
in oxidative stress in the brain but we found that Parl deficiency
has severe consequences on mitochondrial calcium metabolism.
Mitochondrial calcium is a critical determinant of cell death
including necrosis and is particularly important in neurodegen-
erative disorders including Parkinson’s, amyotrophic lateral scle-
rosis, Huntington disease (26), and hereditary neurodegenera-
tive diseases caused by mutations in another mitochondrial pro-
tease, AFG3L2 (42). Moreover, mitochondrial function is bidi-
rectionally related to mitochondrial structure, and we found that
Parl-/- brain mitochondria progressive accumulate morphological
abnormalities implying that Parl plays a role, whether direct or
indirect, in mitochondrial ultrastructure. It is thus plausible that
the drastic neurodegeneration that we report in Parl-/- mice is
due to a combination of mitochondrial functional and structural
defects that progressively accumulate culminating in neuronal
necrosis.
Our work indicates that Parl has a constitutive physiological
role in keeping mitochondrial function and structural integrity in
check, with crucial consequences for the nervous system.
MATERIALS AND METHODS
Details are provided in SI Appendix, SI Materials and Methods, including de-
tails on mice, pathology, ISH, electron microscopy, subcellular fractionation,
Immunoblot, BNGE, high-resolution respirometry, mitochondrial respiratory
chain enzyme CoQ, ROS production, protein carbonylation, mitochondrial
calcium, antibodies, proteomics, plasmids, mtDNA quantiﬁcations, cell cul-
ture, statistics.
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